Rab7: A Key to Lysosome Biogenesis<sup><a href="#FN182" rid="FN182" class=" fn">V⃞</a></sup>
Abstract
The molecular machinery behind lysosome biogenesis and the maintenance of the perinuclear aggregate of late endocytic structures is not well understood. A likely candidate for being part of this machinery is the small GTPase Rab7, but it is unclear whether this protein is associated with lysosomes or plays any role in the regulation of the perinuclear lysosome compartment. Previously, Rab7 has mainly been implicated in transport from early to late endosomes. We have now used a new approach to analyze the role of Rab7: transient expression of Enhanced Green Fluorescent Protein (EGFP)–tagged Rab7 wt and mutant proteins in HeLa cells. EGFP-Rab7 wt was associated with late endocytic structures, mainly lysosomes, which aggregated and fused in the perinuclear region. The size of the individual lysosomes as well as the degree of perinuclear aggregation increased with the expression levels of EGFP-Rab7 wt and, more dramatically, the active EGFP-Rab7Q67L mutant. In contrast, upon expression of the dominant-negative mutants EGFP-Rab7T22N and EGFP-Rab7N125I, which localized mainly to the cytosol, the perinuclear lysosome aggregate disappeared and lysosomes, identified by colocalization of cathepsin D and lysosome-associated membrane protein–1, became dispersed throughout the cytoplasm, they were inaccessible to endocytosed molecules such as low-density lipoprotein, and their acidity was strongly reduced, as determined by decreased accumulation of the acidotropic probe LysoTracker Red. In contrast, early endosomes associated with Rab5 and the transferrin receptor, late endosomes enriched in the cation-independent mannose 6-phosphate receptor, and the trans-Golgi network, identified by its enrichment in TGN-38, were unchanged. These data demonstrate for the first time that Rab7, controlling aggregation and fusion of late endocytic structures/lysosomes, is essential for maintenance of the perinuclear lysosome compartment.
ACKNOWLEDGMENTS
We thank B. Hofflack, M. Fukuda, K. von Figura, J. Gruenberg, S. Carlsson, and M. McNiven for their generous gifts of antibodies, and J. Rygaard and J.P. Stenvang for the FACS analysis. We also thank P. Alifano for critical reading of the manuscript and Ulla Hjortenberg, Mette Ohlsen, Keld Ottosen, and Kirsten Pedersen for excellent technical help. This work was supported by grants from the Consiglio Nazionale delle Richerche (Progetto Finalizzato Biotecnologie) and the European Community (CT96-0020) to C.B. and by grants from the Danish Cancer Society, the Danish Medical Research Council, the John and Birthe Meyer Foundation, the Novo Nordisk Foundation, the Human Frontier Science Program (RG404/96 M), and the European Community (CT96-0058) to B.v.D. J.M. was supported by European Community grant CT96-0020, and P.N. was supported by European Community grant CT96-0058. P.T. was working in the van Deurs laboratory with the support of a Ph.D. grant from the Faculty of Health Sciences, University of Copenhagen.
Abbreviations used:
| CI-MPR | cation-independent mannose 6-phosphate receptor |
| EGFP | Enhanced Green Fluorescent Protein |
| Lamp | lysosome-associated membrane protein |
| TCA | trichloroacetic acid |
| TGN | trans-Golgi network |
Footnotes
Online version of this article contains video material. Online version available at www.molbiolcell.org.










